VANGUARD GROUP INC 13D and 13G filings for Co-Diagnostics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-30 2:57 pm Sale | 2025-09-30 | 13G | CO-DIAGNOSTICS INC CODX | VANGUARD GROUP INC | 56,865 3.540% | -2,511 (-4.23%) | Filing |
| 2024-02-13 5:02 pm Unchanged | 2023-12-29 | 13G | CO-DIAGNOSTICS INC CODX | VANGUARD GROUP INC | 59,376 5.820% | 0 (Unchanged) | Filing |
| 2023-02-09 11:15 am Sale | 2022-12-30 | 13G | CO-DIAGNOSTICS INC CODX | VANGUARD GROUP INC | 59,376 5.760% | -459 (-0.77%) | Filing |
| 2022-02-09 3:43 pm Purchase | 2021-12-31 | 13G | CO-DIAGNOSTICS INC CODX | VANGUARD GROUP INC | 59,835 5.300% | 6,039 (+11.23%) | Filing |